BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30649487)

  • 1. Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.
    Nassiri F; Tabatabai G; Aldape K; Zadeh G
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i2-i3. PubMed ID: 30649487
    [No Abstract]   [Full Text] [Related]  

  • 2. EANO guidelines for the diagnosis and treatment of meningiomas.
    Goldbrunner R; Minniti G; Preusser M; Jenkinson MD; Sallabanda K; Houdart E; von Deimling A; Stavrinou P; Lefranc F; Lund-Johansen M; Moyal EC; Brandsma D; Henriksson R; Soffietti R; Weller M
    Lancet Oncol; 2016 Sep; 17(9):e383-91. PubMed ID: 27599143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems in treatment for meningiomas].
    Takahashi J; Hashimoto N
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():303-9. PubMed ID: 16201539
    [No Abstract]   [Full Text] [Related]  

  • 4. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?
    Lunsford LD
    J Neurosurg; 1994 Feb; 80(2):187-90. PubMed ID: 8283254
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of meningiomas.
    Buerki RA; Horbinski CM; Kruser T; Horowitz PM; James CD; Lukas RV
    Future Oncol; 2018 Sep; 14(21):2161-2177. PubMed ID: 30084265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas: An Update on Diagnostic and Therapeutic Approaches.
    Zada G; Jensen RL
    Neurosurg Clin N Am; 2016 Apr; 27(2):xiii. PubMed ID: 27012390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
    Huang RY; Bi WL; Weller M; Kaley T; Blakeley J; Dunn I; Galanis E; Preusser M; McDermott M; Rogers L; Raizer J; Schiff D; Soffietti R; Tonn JC; Vogelbaum M; Weber D; Reardon DA; Wen PY
    Neuro Oncol; 2019 Jan; 21(1):26-36. PubMed ID: 30137421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningioma: management of the most common brain tumour].
    Hundsberger T; Surbeck W; Hader C; Putora PM; Conen K; Roelcke U
    Praxis (Bern 1994); 2016 Apr; 105(8):445-51. PubMed ID: 27078728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningioma.
    Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in multidisciplinary therapy for meningiomas.
    Brastianos PK; Galanis E; Butowski N; Chan JW; Dunn IF; Goldbrunner R; Herold-Mende C; Ippen FM; Mawrin C; McDermott MW; Sloan A; Snyder J; Tabatabai G; Tatagiba M; Tonn JC; Wen PY; Aldape K; Nassiri F; Zadeh G; Jenkinson MD; Raleigh DR;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i18-i31. PubMed ID: 30649489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and translational advances in meningiomas.
    Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors.
    Verbruggen LC; Hudson MM; Bowers DC; Ronckers CM; Armstrong GT; Skinner R; Hoving EW; Janssens GO; van der Pal HJH; Kremer LCM; Mulder RL
    J Neurooncol; 2020 Apr; 147(2):417-425. PubMed ID: 32088813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of malignant meningiomas: diagnosis, characteristics, and treatment.
    Hanft S; Canoll P; Bruce JN
    J Neurooncol; 2010 Sep; 99(3):433-43. PubMed ID: 20730473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality Therapy of Patients with Refractory Meningiomas.
    Ahmad H; Schiff D
    Curr Treat Options Oncol; 2019 May; 20(6):50. PubMed ID: 31073797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
    Strassner C; Buhl R; Mehdorn HM
    Neurol Res; 2009 Jun; 31(5):478-82. PubMed ID: 19500450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honored guest presentation: contemporary treatment of skull base meningiomas.
    Kokkino AJ; Abdel Aziz KM; Tew JM
    Clin Neurosurg; 2000; 46():554-74. PubMed ID: 10944701
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant meningiomas.
    Fountain DM; Young AMH; Santarius T
    Handb Clin Neurol; 2020; 170():245-250. PubMed ID: 32586496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningiomas. Clinical case examples].
    Wilhelm H; Batra M; Honegger J; Paulsen F
    Ophthalmologe; 2013 May; 110(5):408-14. PubMed ID: 23595649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial meningiomas: diagnosis and treatment.
    Chamberlain MC; Blumenthal DT
    Expert Rev Neurother; 2004 Jul; 4(4):641-8. PubMed ID: 15853583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.